TABLE 1.
Characteristics of bacterial strains investigated, including resistance determinants (10, 20), MICs of TGC and COL, FICIs and SBPIs for TGC/COL combinations, and results from time-kill assays
Strain | Feature(s) | TGC MIC (μg/ml) | COL MIC (μg/ml) | FICIa | SBPI | Time-kill assay resultsa |
---|---|---|---|---|---|---|
E. coli NCTC 12241 | Antibiotic-susceptible type strain | 0.064 | 0.75 | 0.625 (I) | 40 | |
E. coli EC5 | ST131 CTX-M-15 producer | 0.064 | 1 | 0.5 (S) | 39.95 | S |
E. coli EC204 | Carbapenem-resistant NDM-1 producer | 0.25 | 0.38 | 0.374 (S) | 24.13 | S |
E. coli EC421 | Carbapenem-resistant NDM-1 producer | 0.16 | 8 | 0.748 (I) | 20.13 | |
E. coli EC405 | Carbapenem-resistant NDM-5 producer | 0.16 | 0.75 | 1 (I) | 10 | |
E. aerogenes NCTC 9753 | Antibiotic-susceptible type strain | 0.16 | 0.75 | 0.56 (I) | 40 | |
E. aerogenes EA2 | Carbapenem-susceptible CTX-M-1 producer | 0.25 | 3 | 0.188 (S) | 39.95 | S |
E. aerogenes EA1 | Carbapenem -resistant (porin loss, AmpC hyperproducer); in vivo derivative of EA2 | 0.125 | 0.38 | 0.75 (I) | 24.13 | |
E. cloacae NCTC 13380 | Antibiotic-susceptible type strain | 0.16 | 0.5 | 0.56 (I) | 39 | |
E. cloacae TGC-R | TGC-resistant efflux mutant | 8 | 1.5 | 0.5 (S) | 8.5 | S |
K. pneumoniae NCTC 9633 | Antibiotic-susceptible type strain | 0.125 | 0.38 | 0.125 (S) | 12 | I |
K. pneumoniae KP52 | Carbapenem-resistant OXA-48 producer | 0.5 | 1 | 0.375 (S) | 12 | S |
K. pneumoniae KPC-3 | Carbapenem-resistant KPC-3 producer | 1 | 0.5 | 0.75 (I) | 9 | |
K. pneumoniae KP51 | Carbapenem-susceptible CTX-M-15 producer | 4 | 0.5 | 0.313 (S) | 9 | S |
K. pneumoniae KP96 | Carbapenem-resistant VIM-1 and KPC-2 producer | 0.5 | 0.38 | 0.531 (I) | 39.95 | |
S. marcescens NCTC 13382 | Antibiotic-susceptible type strain | 0.125 | >256 | 9 (A) | 0.125 | |
S. marcescens | Carbapenem-resistant NDM-1 producer | 1.5 | >256 | 9 (A) | 0.09 | |
S. marcescens SM346 | TGC-resistant efflux mutant | 6 | 2 | 5 (A) | 0.125 |
S, synergy; I, intermediate or additive; A, antagonism.